Celgene Corporation Strategy and SWOT Report

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Quotient Biodiagnostics - Product Pipeline Analysis, 2014 Update

Quotient Biodiagnostics - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • by Global Data
  • September 2014
  • 37 pages

Summary Quotient Biodiagnostics (Quotient) is a medical device company. The company develops, manufactures and markets immunohematology products. Its products include ABORh reagents, rare antisera, reagent red blood cells, anti human globulin reagents, enhancement media and controls, and specialty kits. ...

Industries: Biopharmaceutical | Countries: United States

Growth Hormone Deficiency - Pipeline Review, H2 2014

Growth Hormone Deficiency - Pipeline Review, H2 2014

  • $ 2 000
  • Company report
  • by Global Markets Direct
  • August 2014
  • 111 pages

Growth Hormone Deficiency - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Growth Hormone Deficiency - Pipeline Review, H2 2014', provides an overview of the Growth Hormone Deficiency's therapeutic pipeline. This report provides comprehensive information on the therapeutic development fo ...

Industries: Biopharmaceutical | Countries: United States, World

BioMedical Enterprises, Inc. SWOT Analysis, Strategy, Revenues and Profits

BioMedical Enterprises, Inc. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • August 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. SWOT Analysis report provides you a strategic analysis and detailed ...

Industries: Biopharmaceutical | Countries: United States

Calypte Biomedical Corporation (Symbol:CBMC) SWOT Analysis, Strategy, Revenues and Profits

Calypte Biomedical Corporation (Symbol:CBMC) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • August 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Calypte Biomedical Corporation SWOT Analysis report provides you a ...

Industries: Biopharmaceutical | Countries: United States

QuantRx Biomedical Corporation (Symbol:QTXB) SWOT Analysis, Strategy, Revenues and Profits

QuantRx Biomedical Corporation (Symbol:QTXB) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • August 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. QuantRx Biomedical Corporation SWOT Analysis report provides you a ...

Industries: Biopharmaceutical | Countries: United States

Verenium Corporation (Symbol:VRNM) SWOT Analysis, Strategy, Revenues and Profits

Verenium Corporation (Symbol:VRNM) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • August 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Verenium Corporation SWOT Analysis report provides you a strategic ...

Industries: Biopharmaceutical | Countries: United States

Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024

Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024

  • $ 1 899
  • Industry report
  • by Roots Analysis Private Ltd.
  • August 2014
  • 214 pages

INTRODUCTION Antibody drug conjugates (ADCs) are a new class of therapeutic agents, gaining increasing attention from both large and small pharmaceutical companies. Generally addressed as the marriage of an antibody with a toxic drug / chemotherapy drug, these conjugates are believed to be more efficient ...

Industries: Biopharmaceutical | Countries: United States

AvidBiotics Corp. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

AvidBiotics Corp. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • by Global Data
  • July 2014
  • 17 pages

Summary AvidBiotics Corp. (AvidBiotics) is a non antibody protein company. The company develops non-antibody proteins which targets bacteria, viruses or cancer cells for human therapeutic and prophylactic uses. It develops human health care, food safety, and other products. AvidBiotics' avidocin and ...

Industries: Biopharmaceutical | Countries: United States

Gallus BioPharmaceuticals, LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Gallus BioPharmaceuticals, LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • by Global Data
  • July 2014
  • 17 pages

Summary Gallus BioPharmaceuticals, LLC (Gallus) is a biopharmaceutical company. The company provides contract manufacturing services for the pharmaceutical and biotechnology industry. Its services include protein expertise, process development, analytical method development, process validation, regulatory ...

Industries: Biopharmaceutical | Countries: United States

NGM Biopharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

NGM Biopharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • by Global Data
  • July 2014
  • 22 pages

Summary NGM Biopharmaceuticals, Inc. (NGM) is a pharmaceutical company. The company manufactures pharmaceutical ingredients and intermediate products that are used in animal and human health. Its products include finished dosage forms, diminazene aceturate granules and homidium chloride tablets. NGM ...

Industries: Biopharmaceutical | Countries: United States

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.